Corcept Therapeutics(us:CORT)

114.58

+109.74%

Updated on 2025-03-31

Open:94.72
Close:114.58
High:117.33
Low:87.58
Prev Close:54.63
Volume:14.26M
Turnover:1.47B
Turnover Ratio:13.51%
Shares:105.50M
MarketCap:12.09B
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-3012951750.09%442
2024-03-313179244674088.87%51107129
2023-12-312958442282581.64%5484117
2023-09-302558130936778.94%3881105
2023-06-302558038739378.42%2461130
2023-03-312638565421679.38%3585112
2022-12-312698329857577.25%3795100
2022-09-302538621122080.11%319096
dateorgNametotalratiochangeShareschangeRatio
2024-06-30Blackrock Inc.1653915915.84%-286922-1.70%
2024-06-30Vanguard Group Inc95537069.15%-12076-0.13%
2024-06-30Ingalls & Snyder Llc82381067.89%-65041-0.78%
2024-06-30Renaissance Technologies Llc69125716.62%-205800-2.89%
2024-06-30Parallel Advisors, Llc38157603.65%830.00%
2024-06-30State Street Corp34993703.35%-76156-2.13%
2024-06-30Dimensional Fund Advisors Lp26763352.56%1086584.23%
2024-06-30Novo Holdings A/S24113622.31%0
2024-06-30Geode Capital Management, Llc22792882.18%1215035.63%
2024-06-30Boston Trust Walden Corp15838991.52%-251194-13.69%

About

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
Address:149 Commonwealth Drive

Market Movers